secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001213900-24-090121
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex appoints Dr. Luigi Barbato as CMO; base salary $375K, RSU grant of 100,476 shares vesting over 3 years
--------------------------------------------------------------------------------

- Dr. Barbato appointed Chief Medical Officer effective October 21, 2024; reports to CEO Joel Latham.
- Base salary of $375,000 with target annual incentive up to 20% of base salary.
- Granted 100,476 restricted stock units (approx. $200K / 5-day VWAP) vesting in 3 equal annual installments.
- Most recently Global Medical Lead at Jazz Pharmaceuticals; prior roles at AbbVie, Biogen, Novartis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/0001213900-24-090121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/ea0218506-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-090121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer